U.S. drug regulators are edging closer to approving the first-ever medicine derived from a marijuana plant, an experimental epilepsy treatment developed by GW Pharmaceuticals Plc. On Thursday, a panel of outside advisers to the Food […]
French biotech Adocia has announced the initiation of a Phase I study of BioChaperone Pramlintide Insulin, a treatment that could better regulate glucose levels in type 1 diabetes patients. The product is made up of […]
Pharmaceutical company Novo Nordisk has announced it will work with The International Committee of the Red Cross (ICRC) and the Danish Red Cross (DRC) to tackle chronic care in humanitarian crises. The partnership will tackle […]
The EMA has announced it has completed the reallocation of the medicines that the UK’s national regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), currently regulates. Despite efforts from the UK to remain linked […]
Sempre Health has announced that it is collaborating with Novo Nordisk on a pilot programme aimed at delivering cheaper diabetes drugs to patients. Sempre Health’s ‘behaviour-based healthcare pricing platform’ adjusts the cost of medication over […]